Recent in-depth molecular profiling and studies of the genetic landscape of pediatric low-grade gliomas led to the discovery of the paramount role of frequent upregulation of RAS/MAPK and mTOR signaling in the tumorigenesis and progression of PLGGs. The gene discussed is MTOR; the disease is glioma.